• Report on the use of the CellHesion 200 system to study Cellular Adhesion at the Molecular Level in the field of Diabetes 

Microscopy & Microtechniques

Report on the use of the CellHesion 200 system to study Cellular Adhesion at the Molecular Level in the field of Diabetes 

Mar 27 2014

Dr Paul Squires and Dr Claire Hills from the School of Life Sciences (SLS) at the University of Warwick have international expertise in cell biology, signalling and endocrinology. They are using the JPK CellHesion® 200 system to nurture multi-disciplinary research between SLS and the School of Engineering (Dr K-K Liu) in addition to external collaborations, e.g. Professor Peter Jones (King’s College London). The innovative nanotechnology is being used to explore a range of problems in biomedicine, biology and pharmacokinetics related to the field of energy homeostasis and diabetes, and the state-of-the-art resource facilitates their experimental work on models of the disease, bridging the gap between basic science, nanotechnology and medicine for developing the next-generation of therapies.

The CellHesion® 200 is an integrated system designed to measure cell-cell and cell-substrate interactions. Epithelial tubular cells of the kidney are large and have an elastic membrane. To resolve complete separation of two adherent cells we require a system with a pulling length of up to 100 μm. Other AFM instruments cannot offer this level of manoeuvrability and are unable to record full separation of large cells. The CellHesion® 200 system can also be used to quantify membrane rigidity and cellular responses to external mechanical stress. This facilitates investigations into glucose-evoked changes in TRPV4-mediated mechano-sensation in the renal collecting duct.

The group have published several papers relating to diabetes research where the CellHesion system has been integral to their investigations. These include papers in the journals of Experimental Diabetes Research, Diabetologia, Febs Lettersand Cell Physiology & Biochemistry. Most recently, the group has reported results on the study of the effects of the ‘party drug’ ketamine and its effect on renal and bladder behaviour were CellHesion is being used to assess if early changes in candidate protein expression at the adherens junction functionally uncouple cells ahead of overt loss in epithelial function.

Commenting about the use of the CellHesion® 200, Dr Squires said: “To resolve complete separation of two adherent cells we require a system with a pulling length of up to 100 μm. The CellHesion system is the only AFM-based instrument on the market capable of allowing this degree of separation


Digital Edition

Lab Asia 31.2 April 2024

April 2024

In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...

View all digital editions

Events

Microbiology Society Annual Conference 2024

Apr 08 2024 Edinburgh 2024

analytica 2024

Apr 09 2024 Munich, Germany

ChemBio Finland 2024

Apr 10 2024 Helsinki, Finland

Analytica Anacon India & IndiaLabExpo

Apr 15 2024 Mumbai, India

Analitika Expo 2024

Apr 16 2024 Moscow, Russia

View all events